Table 2.

Changes in Outcomes of Core Measures Between 1 Year Pre-MDR and the First Year of MDR

Core measure	Pre-MDR*			MDR†			P value
	Eligible‡ (#)	Success rate (%)	95% CI (%)	Eligible‡ (#)	Success rate (%)	95% CI (%)
Heart failure	780	65	62–69	781	76	73–79	<.001
Discharge instructions	261	21	17–27	267	48	41–54	<.001
Left ventricular ejection fraction assessment	347	93	89–95	352	94	91–97	.334
Angiotensin converting enzyme inhibitor	119	76	68–84	116	80	72–87	.491
Smoking cessation counseling	53	77	64–88	46	91	79–98	.060
Acute myocardial infarction	201	89	83–93	243	96	93–98	.002
Aspirin prescribed at discharge	80	95	88–99	83	99	94–100	.160
Angiotensin converting enzyme inhibitor	26	81	61–93	38	89	75–97	.325
Beta-blocker prescribed at discharge	81	90	81–96	104	97	92–99	.046
Smoking cessation counseling	14	57	29–82	18	94	73–100	.011
Community-acquired pneumonia	351	27	23–32	385	70	65–74	<.001
Pneumococcal vaccination	261	10	7–14	303	64	58–69	<.001
Smoking-cessation counseling	90	78	68–86	82	91	83–96	.014

*Pre-MDR from July 2002 to June 2003. MDR denotes multidisciplinary rounds.

^†MDR from July 2003 to June 2004

^‡Eligible patients are those who meet JCAHO criteria for receiving the specified core measure